We now show that the cardiac glycoside ouabain, an inhibitor of Na,K-ATPase, inhibits EGFR signaling in medulloblastoma cells, but not glioblastoma cells, and prevents EGF-induced cell migration, a prerequisite for an invasive phenotype. Here, EGF is linked to glioblastoma.